Desferal

Desferal

deferoxamine

Manufacturer:

Novartis

Distributor:

Zuellig
Concise Prescribing Info
Contents
Desferrioxamine methane sulfonate
Indications/Uses
Monotherapy Fe chelation treatment for chronic Fe overload eg, transfusional hemosiderosis, as seen in thalassemia major, sideroblastic anemia, auto-immune hemolytic anemia & other chronic anemias. Idiopathic (primary) hemochromatosis in patients in whom concomitant disorders (eg, severe anemia, cardiac disease, hypoproteinemia) preclude phlebotomy. Fe overload associated w/ porphyria cutanea tarda in patients unable to tolerate phlebotomy. Treatment for acute Fe poisoning. Treatment for chronic Al overload in patients w/ end-stage renal failure (under maintenance dialysis) w/ Al-related bone disease, dialysis encephalopathy or Al-related anemia. Diagnosis of Fe or Al overload.
Dosage/Direction for Use
Chronic Fe overload 20-60 mg/kg daily. Patients w/ serum ferritin level <2,000 ng/mL 25 mg/kg/day; serum ferritin level 2,000-3,000 ng/mL 35 mg/kg/day; higher serum ferritin up to 55 mg/kg/day. Acute Fe poisoning Up to 80 mg/kg/day. Chronic Al overload 5 mg/kg once wkly. Test for Fe overload 500 mg IM. Infusion test for Al overload 5 mg/kg as slow IV infusion.
Contraindications
Special Precautions
Rapid IV infusion may lead to hypotension & shock (eg, flushing, tachycardia, circulatory collapse & urticaria). Disturbances of vision & hearing. Monitor for changes in renal function. Growth retardation (especially in patients <3 yr). Monitor body wt & longitudinal growth every 3 mth in ped patients. Acute resp distress syndrome, following high IV doses. Increased susceptibility to infections eg, w/ Yersinia enterocolitica & Yersinia pseudotuberculosis. Rare cases of mucormycosis. Cardiac impairment w/ high doses of vit C. In patients w/ Al-related encephalopathy, high doses may exacerbate neurological dysfunction. Treatment of Al overload may result in hypocalcemia & aggravation of hyperparathyroidism. Renal impairment. May affect ability to drive or operate machinery. Pregnancy & lactation.
Adverse Reactions
Arthralgia, myalgia; inj site reaction eg, pain, swelling, infiltration, erythema, pruritus, eschar, crust. Headache; nausea; urticaria; growth retardation & bone disorder (eg, metaphyseal dysplasia) in higher doses & young childn; pyrexia.
Drug Interactions
Risk of temporary impairment of consciousness w/ prochlorperazine. Increased risk of impairment of cardiac function w/ high dose vit C. Gallium-67 imaging results may be distorted.
MIMS Class
Antidotes & Detoxifying Agents
ATC Classification
V03AC01 - deferoxamine ; Belongs to the class of iron chelating agents. Used in the management of iron poisoning.
Presentation/Packing
Form
Desferal powd for soln for inj 500 mg
Packing/Price
10 × 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in